
SanoGraft® is a single layer allograft derived from amnion.
SanoGraft® is processed in compliance with the United States Food and Drug Administration current Good Tissue Practices (cGTP) Regulations and the Association for Advancing Tissue and Biologics.
SanoGraft® is regulated under Section 361 of the PHS Act and FDA 21 CFR Part 1271 and is intended for homologous use.